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Chronic kidney disease (CKD) is associated with sympathetic hyperactivity and impaired
blood pressure control reflex responses, yet direct evidence demonstrating these
features of autonomic dysfunction in conscious animals is still lacking. Here wemeasured
renal sympathetic nerve activity (RSNA) and mean arterial pressure (MAP) using
telemetry-based recordings in a rat model of CKD, the Lewis Polycystic Kidney (LPK) rat,
and assessed responses to chemoreflex activation and acute stress. Male LPK and Lewis
control animals (total n = 16) were instrumented for telemetric recording of RSNA and
MAP. At 12–13 weeks-of-age, resting RSNA and MAP, sympathetic and haemodynamic
responses to both peripheral (hypoxia: 10% O2) and central chemoreflex (hypercapnia:
7%CO2) activation and acute stress (open-field exposure), were measured. As indicators
of renal function, urinary protein (UPro) and creatinine (UCr) levels were assessed. LPK rats
had higher resting RSNA (1.2 ± 0.1 vs. 0.6 ± 0.1µV, p < 0.05) and MAP (151 ± 8 vs.
97 ± 2mmHg, p < 0.05) compared to Lewis. MAP was negatively correlated with UCr
(r = −0.80, p = 0.002) and positively correlated with RSNA (r = 0.66, p = 0.014),
with multiple linear regression modeling indicating the strongest correlation was with Ucr.
RSNA and MAP responses to activation of the central chemoreflex and open-field stress
were reduced in the LPK relative to the Lewis (all p < 0.05). This is the first description
of dual conscious telemetry recording of RSNA and MAP in a genetic rodent model of
CKD. Elevated RSNA is likely a key contributor to the marked hypertension in this model,
while attenuated RSNA and MAP responses to central chemoreflex activation and acute
stress in the LPK indicate possible deficits in the neural processing of autonomic outflows
evoked by these sympathoexcitatory pathways.
Keywords: renal sympathetic nerve activity, blood pressure, chemoreflex, open-field stress, hypertension,
polycystic kidney disease, telemetry
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Introduction
Sympathetic nervous system (SNS) hyperactivity is synonymous
with chronic kidney disease (CKD), contributing to
hypertension, renal disease progression, and consequent
cardiovascular morbidity and mortality (Penne et al., 2009;
Grassi et al., 2011). Plasma catecholamine levels (Zoccali et al.,
2002; Grassi et al., 2011) and renal noradrenaline spillover
(Schlaich et al., 2013) are increased, and direct measurements
of muscle sympathetic nerve activity (SNA) reveal elevated
tonic levels (Neumann et al., 2007; Grassi et al., 2011; Schlaich
et al., 2013). However, despite the various approaches to
quantify sympathetic activity in humans and experimental
animals, each has inherent limitations. Measurement of plasma
catecholamine levels can reveal global activity but not the
discrete contributions of organ-specific sympathetic nerve
beds and noradrenaline spillover studies, while organ specific,
must take into consideration not only SNA but also altered
neurotransmitter uptake as an underlying mechanism. Elevated
levels of muscle SNA features in many cardiovascular diseases
and as a tool has provided an incredibly valuable snapshot into
SNA at both the multiunit and single unit recording level in
humans (Lambert et al., 2008) and has been used to assess for
example the impact of renal denervation on muscle SNA in
essential hypertension (Hering et al., 2013), however muscle
SNA cannot provide mechanistic data as to what pattern of SNA
is influencing visceral organs such as the kidney (Grassi et al.,
2015) and it does not provide a long-term monitoring approach.
Direct recordings of SNA to specific organ beds can be acquired
from acute recordings in unconscious animals (Yao et al.,
2015), however these may be unavoidably confounded by the
effect of anesthetic on both SNA and blood pressure. Urethane
anesthesia, for example, has been shown to both promote
and inhibit SNA (Shimokawa et al., 1998; Wang et al., 2014)
and altered baseline levels of blood pressure due to anesthetic
will alter SNA through baroreflex mechanisms. Many of the
reflex autonomic responses tested through pharmacological
manipulation of blood pressure may also be influenced by
anesthesia. For example responses to the ganglionic blocker
hexamethonium have been shown to have different responses
on sympathetic control of blood pressure in anesthetized vs.
conscious animals, in both normotensive and hypertensive
models (Biancardi et al., 2007).
Knowing the baseline level of SNA to a specific target organ
can be of critical importance. For example, increased sympathetic
outflow to the kidney may have a greater role in the long-term
control of blood pressure in CKD, given the role of renal SNA
(RSNA) in not only altering blood flow, but also regulating
renin secretion and salt and water reabsorption (Johns et al.,
2011). This is supported by recent evidence showing that renal
denervation, using a catheter-based approach that disrupts renal
sympathetic nerves in the adventitia of the renal arteries, can
mitigate sympathetic hyperactivity in CKD patients, contributing
to not only reductions in blood pressure but also improving
renal haemodynamics, enhancing glomerular filtration rate,
and reducing albuminuria (Hering et al., 2012; Kiuchi et al.,
2013; Schlaich et al., 2013). Our current direct knowledge of
RSNA and autonomic reflex control in CKD is still limited
however.
The Lewis Polycystic Kidney (LPK) rat is a model of
nephronophthisis, a form of autosomal recessive polycystic
kidney disease arising from a spontaneous mutation in the Nek8
gene (McCooke et al., 2012). We have previously demonstrated
both indirect and direct evidence for sympathetic overactivity
in the LPK. Indirectly, hypotensive responses to ganglionic
blockade (Phillips et al., 2007; Ameer et al., 2014), bradycardic
responses to β1-adrenoceptor blockade (Harrison et al., 2010)
and low-frequency power of systolic blood pressure variability
(Harrison et al., 2010; Hildreth et al., 2013b) are all increased
in the LPK. Directly, we have recently shown that RSNA in
anesthetized animals display elevated absolute baseline tonic
levels (Salman et al., 2014, 2015; Yao et al., 2015). Given the
potential effect of anesthesia on SNA, which may be influenced
to a greater degree in the disease state (Hildreth et al., 2013a),
a key objective of the present study was to record RSNA
in conscious unrestrained animals using telemetry, examining
the hypothesis that a sustained elevation in RSNA is a key
pathological feature of CKD. We also sought to identify if altered
sympathetic activity in the conscious LPK is associated with
deficits in regulatory pathways known to impact autonomic
neuroregulation of the cardiovascular system including the
chemoreceptor reflex and behavioral stress. Tonic activation of
excitatory chemoreceptor afferents has been proposed as a driver
of elevated SNA in CKD patients (Hering et al., 2007; Despas
et al., 2009) and we have recently shown under anesthetized
conditions that the LPK animals have impaired peripheral and
central chemoreflex responses (Yao et al., 2015). Accordingly, our
second aim was to assess RSNA and blood pressure responses
to central (hypercapnia) and peripheral (hypoxia) chemoreceptor
stimulation in the conscious LPK. Another potential contributor
to sympathoexcitation in CKD is altered reactivity to stress, with
exaggerated sympathetic responses to acute stress reported in
other hypertensive models (DiBona et al., 1995; Head and Burke,
2004; D’Angelo et al., 2006). In CKDhowever, results are variable,
with reports of unchanged (Agarwal et al., 1991) or exaggerated
(Seliger et al., 2008) haemodynamic response to mental stressors
documented. Therefore, our third aim was to assess sympathetic
and blood pressure reactivity to acute stress in the conscious LPK.
Materials and Methods
Animals
Telemetry probes were implanted in male Lewis (n = 13) and
LPK (n = 9) rats. From the control group, 9 provided successful
recordings of both SNA and blood pressure, while from the
LPK group, 7 were successful recordings. Those animals that did
not provide dual recordings for the duration of the study were
removed from the study (final n = 16). Animals were kept
under a 12-h light/dark cycle and received a standard pellet diet
and water ad libitum. All studies were approved by the Animal
Ethics Committee of Macquarie University and carried out in
accordance with the Australian Code of Practice for the Care and
Use of Animals for Scientific Purposes (8th Edition, 2013).
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Telemetry Probe Implantation
At 10–11 weeks of age, rats underwent surgery to implant a
telemeter equipped with nerve recording electrodes and arterial
catheter (Model TR46SP/56SP,Telemetry Research/Millar,
Auckland, New Zealand). Animals were anesthetized with
isoflurane (5% in 100% O2) for induction and 1–3% for
maintenance. Pre-operative pain relief (carprofen 2.5mg/kg
s.c., Norbrook Laboratories, VIC, Australia) and antibiotic
(cephazolin 55mg/kg i.m., Hospira Pty Ltd, VIC, Australia)
were administered. An abdominal and dorsal skin incision
was made and the nerve recording electrode subcutaneously
tunneled from the abdominal through to dorsal incision site.
The left kidney was exposed retroperitoneally and a 2-mm
portion of the renal nerve, coursing between the abdominal
aorta and left renal artery, isolated. The recording electrode was
anchored to the aorta and renal artery using non-absorbable
7/0 prolene sutures and the renal nerve gently placed on the
electrode and embedded in a silicone elastomer (Kwik-sil R©,
World Precision Instruments, FL, USA). The ground electrode
was sutured to the flank muscles exterior to the dorsal incision
site and the dorsal incision closed. The blood pressure catheter
was placed by one of two methods depending upon catheter
type. Either, the peritoneal cavity was exposed and the catheter
(Millar type/TR56SP) was inserted into the abdominal aorta,
such that the tip of the catheter was distal to the renal artery. The
catheter was secured in place using a plastic mesh (Telemetry
Research) and cyanoacrylate cement (Histoacryl R©, B Braun,
NSW, Australia), and lidocaine (1%, Pfizer, NSW, Australia)
applied to induce vasodilation and improve hind limb blood
flow. Alternatively, the blood pressure catheter (fluid-filled
type/TR46SP) was placed into the femoral artery with the
probe body placed within the peritoneal cavity as we have
described previously (Hildreth et al., 2013b). Supplemental fluids
were provided (saline, 6ml/kg i.p.) and the peritoneal cavity
closed. All skin incisions were closed using wound closure clips.
Following cessation of anesthesia, post-operative pain relief
was provided [buprenorphine (Temgesic R©, Reckitt Benckiser,
NSW, Australia, 50µg/kg s.c.). Rats were allowed to recover
for at least 1 week in order to re-establish circadian rhythms
(Hildreth et al., 2013b). Pain relief (carprofen, 2.5mg/kg, s.c.
and/or buprenorphine, 50µg/kg s.c.) and supplemental fluid
therapy (up to 60ml/kg/day 0.9% saline and/or 5% glucose s.c.)
were administered as required.
Experimental Protocol
All protocols were carried out when animals were aged between
12 and 13 weeks over a ∼7-day period, allowing a minimum
1 week post-surgical recovery period for reestablishment of
circadian rhythms, adequate wound healing and increase
in body weight and food and water intake. Animals were
individually housed and RSNA and blood pressure data acquired
using a receiver (TR162 or TR180: Telemetry Research/Millar)
interfaced with a CED Micro 1401 data acquisition system
(Cambridge Electronic Designs Ltd, Cambridge, UK). A battery
charging pad (TR802/TR180 Telemetry Research/Millar) was
placed under each individual animal cage. The blood pressure
signal was sampled at a minimum of 500Hz and RSNA at
2 kHz and continuously displayed on Spike 2 software (v7,
CED Ltd., Cambridge, UK). The original RSNA signal was
amplified, filtered between 50 and 2000Hz, full-wave rectified
and integrated (1 s smoothing constant). All experiments were
conducted between 9:00 a.m. and 5:00 p.m. Each rat underwent
no more than one study per day. Resting data was collected
at the beginning of the experimental period. Chemoreflex and
stress response experiments (see below) were then performed
in random order. Ganglionic blockade was the last protocol
undertaken. Note not all animals contributed to the data set for
each protocol.
Resting Data
Blood pressure and RSNA were recorded for 5min every 15min
from 9:00 a.m. to 5:00 p.m. over two consecutive days. No other
intervention was undertaken on these days.
Chemoreceptor Reflex
Animals were placed in a custom-made plexiglass chamber to
which they were previously acclimatized. The chamber was
initially filled with medical grade air [21% O2 balance N2 (BOC
Ltd, NSW, Australia),0.5–1 L/min] and O2 and CO2 levels
continuously monitored (CapStar-100 CO2 analyser
R©, CWE
Inc., Ardmore, PA, USA and Gas analyser R©, ADInstruments
Pty Ltd, NSW, Australia). Once the animal was resting quietly,
as indicated by stable measurements of mean arterial pressure
(MAP) and RSNA, a 5-min baseline recording was obtained.
Following this, the chamber was flushed with either a hypoxic
(10% O2 balance N2, BOC Ltd,) or hypercapnic (7% CO2 balance
O2, BOC Ltd,) gas mixture to activate the peripheral and central
chemoreceptors, respectively. Approximately 15 s were required
to reach the target concentration of O2 (10%) and CO2 (7%)
within the chamber. Reducing inspired O2 from 21 to ∼10% in
conscious rats has been shown previously to effectively reduce
PaO2, but not PaCO2, while increasing inspired CO2 from 0
to ∼7% results in an increase in PaCO2without a change in
PaO2(Pepelko and Dixon, 1975). Animals were exposed to these
gas mixtures for no more than 5min, following which the
chamber was flushed with medical grade air. Following a 10–
20min recovery period, another 5min baseline recording was
obtained and the chamber was filled with the alternate gaseous
mixture and MAP and RSNA recorded for another period of
5min. The order of gas exposure was randomized and at the end
of the experiment, the rat was returned to its home cage.
Open-field Stress
Baseline levels of MAP and RSNA were recorded for 10min
while the animal was in its home cage. The animal was then
gently transferred into a brightly lit open field (∼90 cm diameter
circular chamber with 40 cm wall) and the MAP and RSNA
recorded for 40min. The animal was then returned to its home
cage.
Ganglionic Blockade
Baseline MAP and RSNA was recorded for 5min while
the animal was in its home cage. The ganglionic blocker,
hexamethonium (20mg/kg s.c., Sigma Aldrich, NSW, Australia)
was then administered and MAP and RSNA recorded for at least
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30min. The peak response to hexamethonium however was seen
in under 10min in both strains.
Indicators of Renal Function
Animals were individually held in metabolic cages (Tecniplast,
NSW, Australia) for 24 h to collect urine samples and determine
24 h urine production and water consumption. Urine was then
centrifuged at 3000 rpm for 5min and stored at −20◦C until
further assayed for urinary protein (UPro) and creatinine (UCr)
using an IDEXX VetLab analyser (IDEXX Laboratories Pty Ltd.,
NSW, Australia).
Euthanasia
After all protocols had been undertaken, rats were euthanased
with an overdose of 60mg/kg sodium pentobarbital i.p.
(Lethabarb Euthanasia R©, Virbac Pty Ltd, NSW, Australia) and
death levels of RSNA recorded.
Data Analysis
All data was analyzed oﬄine using Spike 2 software and
GraphPad Prism (GraphPad Prism software v6 Inc., La Jolla, CA,
USA). Background nerve activity acquired following ganglionic
blockade was subtracted from all RSNA recordings. The level
of nerve activity following ganglionic blockade was compared
against that obtained following euthanasia and the quality of
nerve activity verified by assessing the pulse modulation of RSNA
(Figure 1) as described previously (Guild et al., 2012; Stocker and
Muntzel, 2013).
Resting Data
From the MAP and RSNA recording taken between 9:00 a.m. to
5:00 p.m., a 3-h period, where no signal dropout was observed
was identified for each animal. Care was taken to ensure that
the time of data analysis was not biased toward morning vs.
afternoon in the Lewis vs. LPK, and thus the 3-h periods were
randomly distributed. Blood pressure and RSNA was averaged
over each 3-h period over the two consecutive days to create one
estimate for each variable per animal.
Chemoreflex Data
To temporally capture changes in the chemoreflex response,
blood pressure, and nerve responses were averaged into 1-min
bins. The level of RSNA, determined during the 1min period
immediately prior to exposure to either hypoxic or hypercapnic
gas mixture was set as 100%. Maximum changes in RSNA (µV)
relative to the 1min baseline were also measured. Changes in
MAP were expressed relative to the level of MAP 1min prior to
chemoreflex activation.
Open-field Stress
The response to exposure to the open field chamber was evident
in less than 10min after initial exposure and consequently, only
the first 10min of data acquired was analyzed. To temporally
capture changes during the open-field exposure, blood pressure,
and nerve responses were averaged into 2-min bins. The averaged
level of MAP and RSNA determined during the 2min period
immediately prior to exposure to the open-field was set as 100%
and changes then expressed relative these baseline levels.
Ganglionic Blockade
Maximum MAP and RSNA responses to hexamethonium were
measured relative to a 5-min baseline of these variables.
Correlation of MAP with Indicators of Renal Function
and RSNA
In order to determine if there was any relationship between
MAP and the indicators renal function [UPro, UCr and urinary
protein: creatinine ratio (UPC)] and/or RSNA, and the relative
strength of the relationships, multiple linear regression modeling
was undertaken, using the IBM Statistical Package for the
Social Sciences (SPSS; v22, IL, USA). MAP was set as the
dependent variable and UPro, UCr, UPC, and RSNA as the
independent variables, using a stepwise selectionmethod of entry
and pairwise exclusion of missing values. Correlation analysis
[Pearson correlation coefficient (r) and significance (1-tailed)]
and results of the full model [adjusted R2 value, being the relative
predictive powers of the model adjusted for degrees of freedom),
significance and β-standardized regression coefficient (β) for the
entered independent variables] are provided. n=Number of data
pairs.
Statistical Analysis
All data are expressed as mean ± standard error of the mean
(SEM). Statistical analysis was performed using GraphPad Prism
(GraphPad Prism software v6 Inc.). A Brown-Forsythe test was
used to determine if there were any differences in the variance,
and if so, the data was log-transformed before statistical analysis.
Baseline levels of MAP and RSNA, renal function, maximum
RSNA (µV) responses to chemoreflex activation and open-field
exposure, responses to ganglionic blockade and stability of RSNA
were analyzed between strains using a two-tailed Student’s t-
test. The effect of chemoreflex activation or stress on the level
of MAP and RSNA was identified within each strain using a
repeated measures One-Way ANOVA. Any strain differences in
the response to chemoreflex activation or stress were identified
using a Two-Way ANOVA. Significance was defined as p ≤ 0.05.
Results
Phenotypic Characteristics of Lewis and LPK
Rats
Daily water intake and urine output, UPro, UPC, MAP, and
resting absolute RSNA were significantly higher in the LPK
rats vs. Lewis controls (Table 1). UCr excretion levels were
significantly lower in the LPK compared with Lewis (Table 1).
MAP was significantly negatively correlated with Ucr(Figure 2A)
and positively correlated with RSNA (Figure 2B). In the
multiple linear regression model however, Ucr was the only
significant predictor variable (n = 11 data pairs, adjusted
R2 = 0.595, β coefficient = −0.797, p = 0.003),
indicating a stronger relationship between MAP and Ucr
than MAP and RSNA. UPro and UPC were not significantly
correlated with MAP and were both excluded from the final
model.
Frontiers in Physiology | www.frontiersin.org 4 August 2015 | Volume 6 | Article 218
Salman et al. Renal SNA in CKD
FIGURE 1 | Top, representative raw data traces of original renal
sympathetic nerve activity (RSNA) and arterial pressure (AP) from
conscious Lewis (left) and Lewis Polycystic Kidney (LPK, right)
rats. Bottom, pulse modulation of RSNA using pulse triggered averages
of AP and integrated RSNA (solid lines) from the same Lewis (left) and
LPK (right) animals. Note the inverse phasic relationship between AP and
RSNA in the pulse-triggered averages, typical of pulse modulation of
SNA.
TABLE 1 | Phenotypic characteristics of Lewis and LPK rats.
Parametern Lewis8 LPK6 p-value
Body weight (g) 332±8 254± 8 <0.0001
Water intake (ml/24 h) 25±1 50± 3 <0.0001
Urine output (ml/24 h) 11±1 51± 3 <0.0001
UPro (g/L) 0.05±0.01 0.89± 0.41 <0.0001
UCr (g/L) 1.2±0.2 0.2± 0.1 0.0006
UPC 0.06±0.02 5.9± 3.2 <0.0001
MAP (mmHg) 97±2 151± 8 <0.0001
RSNA (µV) 0.6±0.1 1.2± 0.1 0.0190
LPK, Lewis Polycystic Kidney; UPro, urinary total protein; UCr , urinary creatinine; UPC,
urinary protein-to-creatinine ratio; RSNA, renal sympathetic nerve activity and MAP, mean
arterial pressure. Results are expressed as mean ± SEM. In the Lewis, UPC was not
calculated in 3/9 animals due to lack of detectable protein levels in the urine. Accordingly,
only 6 Lewis animals were used to compare mean values of UPC. p-values determined
using a two-tailed Student’s t-test. (n) values denoted in subscript and represent the
minimum number in each group.
Responses to Chemoreceptor Reflex Activation
Peripheral Chemoreflex Activation
Exposure to hypoxia (Figure 3) did not significantly changeMAP
in either the LPK or Lewis (both p ≥ 0.05). A trend for an
overall increase in RSNA in response to hypoxia was evident,
most notably in the Lewis animals (Figure 3B), however, Two-
Way ANOVA indicated no significant effect for either strain (p =
0.29) or time (p = 0.15) nor was there an interaction between
strain and time (p = 0.13, n = 9).
Central Chemoreflex Activation
Exposure to hypercapnia produced an increase in MAP (p =
0.005) alongside a trend toward increasing RSNA (p = 0.06) in
the Lewis (Figure 4A). In the LPK, no change in MAP (p = 0.10)
or RSNA (p = 0.68) was observed (Figure 4A). Consequently,
both the pressor and sympathoexcitatory response to exposure
to hypercapnia was greater in the Lewis compared with the LPK
(both p < 0.05, Figure 4B).
Responses to Acute Open-field Stress
Exposure to the open-field environment produced an increase in
both MAP (p < 0.001) and RSNA (p = 0.001) in the Lewis
(Figure 5A). In the LPK, only an increase in RSNA (p = 0.02)
was observed (Figure 5A). Consequently, both the pressor (p =
0.003) and sympathoexcitatory (p < 0.001) response to exposure
to the open-field environment was greater in the Lewis compared
with LPK (Figure 5B).
Responses to Ganglionic Blockade
Administration of hexamethonium produced a fall in MAP and
RSNA in both the Lewis [RSNA: 2.1 ± 0.1 vs. 1.5 ± 0.2µV
(n = 8); MAP: 105 ± 3 vs. 49 ± 4mmHg (n = 7), baseline
vs. hexamethonium; all p < 0.05] and LPK [RSNA: 3.0 ± 0.2
vs. 1.6 ± 0.2µV (n = 4), MAP: 157 ± 5 vs. 56 ± 6mmHg
(n = 4), baseline vs. hexamethonium; all p < 0.05]. The
absolute magnitude of the fall was significantly greater in the
LPK compared to Lewis for MAP (−1.5 ± 8 vs. -56 ± 3mmHg)
and RSNA (−1.3 ± 0.3 vs. −0.6 ± 0.1 µV) (respectively, both
p < 0.05). The level of RSNA recorded following administration
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FIGURE 2 | Correlations of mean arterial pressure (MAP) vs. (A) urinary
creatinine (UCr) and (B) renal sympathetic nerve activity (RSNA), in
Lewis and Lewis Polycystic Kidney (LPK) rats derived from multiple
linear regression (n = 11). Pearson correlation coefficient (r) and significance
are provided for each relationship within the figure panel.
of hexamethonium was not different between Lewis and LPK
and in both groups was comparable to that recorded following
euthanasia [Lewis: 1.5± 0.2 (n = 8) vs. 1.3± 0.2 (n = 9)µV and
LPK: 1.6± 0.2 (n = 4) vs. 1.3± 0.2 (n = 7) µV, hexamethonium
vs. euthanasia; all p > 0.05].
Discussion
This is the first description of conscious concurrent telemetric
recordings of RSNA and blood pressure in a genetic rodent
model of CKD. The major novel findings of the present study
are: (1) LPK rats have sustained elevated absolute RSNA under
conscious conditions compared to Lewis control animals; (2)
MAP is most strongly correlated with urinary creatinine as an
indicator of renal function across both strains of rat, as well
as showing a correlation with RSNA, (3) conscious LPK show
reduced RSNA and MAP responses to central chemoreceptor
reflex activation and acute stress, indicating possible deficits in
the neural processing of autonomic outflows evoked by these
typically sympathoexcitatory pathways. Together, this shows that
in CKD, sympathetic overdrive, as assessed by direct conscious
recording of RSNA, is an archetypal feature, likely contributing to
the maintained hypertensive state, and there is altered reactivity
to reflexogenic and stressful stimuli.
In our study, we used absolute microvolt measures to
report baseline RSNA, and percentage change scores to assess
autonomic reflex responses. The reporting of SNA is a
methodological consideration, as it has been suggested that
FIGURE 3 | Mean arterial pressure (MAP) and renal sympathetic nerve
activity (RSNA) responses to peripheral chemoreflex activation in
Lewis and Lewis Polycystic Kidney (LPK) rats. (A) Data points are 1-min
averages of MAP and RSNA measured for 1min before (time zero) and 5min
during a hypoxic challenge (10% O2). Results are expressed as mean ± SEM.
Minimum n/group = 4. (B) Average change in MAP and RSNA during the
challenge. Results are expressed as mean ± SEM.
absolute levels of SNA in voltage units cannot be compared
between animals, as SNA level is dependent upon conditions at
the recording site, the number and size of the nerve fibers and the
proximity of the active fibers to the electrode (Burke et al., 2011),
which increases variability between different nerve recordings.
Normalizing nerve activity data by setting baseline to 100% and
reporting percentage change scores is proposed to avoid any bias
that would therefore otherwise arise, and allow for significant
differences to be detected in smaller groups of rats. This method,
however, does not allow for comparison of baseline activity or
maximal changes in absolute units (Burke et al., 2011). This has
led some to suggest that reporting properties of nerve activity
using both normalized responses and raw rectified voltage is
extremely valuable (Huber and Schreihofer, 2010).
The use of telemetry to directly record SNA in conscious
animals over a sustained period overcomes many of the
limitations associated with other direct and indirect methods
of determining SNA. It does however have inherent technical
challenges. The surgical procedure and placement of the
telemetry probe is limited by animal size, with >200 grams
being the minimum bodyweight for probe implantation. This
limits the age range of animals that can be studied, which can
be confounded by disease if that is a factor that reduces an
animal’s body weight further. Another key challenge is the ability
to determine sympathetic activity from background or artifact
related noise (Stocker and Muntzel, 2013). In this study, we
obtained successful blood pressure and RSNA recordings from
16 out of 22 (∼70%) of animals implanted with probes, with the
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FIGURE 4 | Mean arterial pressure (MAP) and renal sympathetic nerve
activity (RSNA) responses to central chemoreflex activation in Lewis
and Lewis Polycystic Kidney (LPK) rats. (A) Data points are 1-min
averages of RSNA and MAP measured for 1min before (time zero) and 5min
during a hypercapnic challenge (7% CO2). (B) average change in MAP and
RSNA during the challenge. Results are expressed as mean ± SEM.
*p < 0.05. Minimum n/group = 4.
validity of our recordings confirmed by the burst like activity
evident within the recordings, strong coupling of the SNA to
the cardiac cycle as evidenced by the pulse modulation of SNA,
and the effective elimination of the response after ganglionic
blockade with hexamethonium, indicative of the postganglionic
nature of the signal (Stocker and Muntzel, 2013). Recordings
for a prolonged period require reliable battery capacity and
charging of the battery in-vivo can be problematic, however,
this has recently been greatly facilitated by the use of individual
recharging pads optimized to fit a standard rodent cage, thereby
allowing for continual home cage charging operation. Other
technical difficulties experienced included: signal dropout, which
influenced the recording period over which we could obtain
resting data; activity-induced signal noise; and the ease of data
analysis, which for our study required the generation of custom-
made scripts to analyse the data in our chosen software package.
Our work here confirms our previous studies demonstrating
evidence of increased sympathetic activity in the LPK, as
measured by other direct and indirect approaches (Phillips et al.,
2007; Harrison et al., 2010; Hildreth et al., 2013b; Salman et al.,
2014; Yao et al., 2015). This includes our confirmation of previous
findings that the LPK display enhanced depressor responses to
ganglionic blockade (Phillips et al., 2007; Ameer et al., 2014),
another indicator of increased sympathetic vasomotor tone that
as a methodology has been the subject of some debate (Moretti
et al., 2009). Clinically, elevated SNA in CKD patients is of
marked significance being associated with all-cause mortality
and nonfatal cardiovascular events (Penne et al., 2009), left
FIGURE 5 | (A) Mean arterial pressure (MAP) and renal sympathetic nerve
activity (RSNA) responses to acute open-field stress in Lewis and Lewis
Polycystic Kidney (LPK) rats. Data points are 2-min averages of RSNA and
MAP measured for 2min before (time zero) and the first 10min during acute
stress exposure. (B) Average change in MAP and RSNA during the first 10min
of the acute stress exposure. Results are expressed as mean ± SEM.
***p < 0.001. Minimum n/group = 6.
ventricular hypertrophy (Guízar-Mendoza et al., 2006) and
vascular damage (Bruno et al., 2012). While not indicative of
any causal relationship, our observation of blood pressure being
strongly correlated with urinary creatinine, as an indicator of
declining renal function, as well as having a positive association
with RSNA could offer insight to a potential mechanism
underlying the blood pressure lowering and renoprotective
effects reported after renal denervation in CKD patients (Hering
et al., 2012; Kiuchi et al., 2013; Schlaich et al., 2013) and animal
models (Eriguchi et al., 2015).
Whether the RSNA measures that we have observed in the
LPKmodel reflect SNA to other vascular beds remains unknown.
We have recently shown that in the anesthetized preparation,
simultaneous recordings of lumbar, renal, and splanchnic nerves
in the LPK demonstrate higher baseline absolute levels of SNA
(µV) when compared to Lewis controls (Yao et al., 2015).
Future, studies in conscious animals are required to verify this.
Current evidence suggests that overall activity of the SNS cannot
be simply judged from the recording of a single sympathetic
nerve bed (Knuepfer and Osborn, 2010). For example, in Dahl
hypertensive rats, targeted ablation of the renal nerves and/or
the splanchnic nerves independently influenced MAP, with the
greatest decline in MAP seen in those rats that underwent
both ablations (Foss et al., 2013), suggesting distinct roles for
both the renal and splanchnic sympathetic outflows in driving
hypertension in this model. In contrast, in an angiotensin II-
high salt induced hypertension model, RSNA decreased over the
study period, while lumbar SNAdid not change (Yoshimoto et al.,
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2010) and that SNA to either vascular bed was not critical in the
pathogenesis of angiotensin II-salt hypertension.
We have previously demonstrated that elevated sympathetic
drive in the LPK is associated with an inability to effectively
restrain SNA by the baroreflex (Salman et al., 2014) and that
peripheral and central chemoreflex responses are blunted in
these animals (Yao et al., 2015). An objective of the present
work was to assess if the LPK display comparable chemoreflex
abnormalities in the conscious state and to test a psychological
stressful stimulus, being another reflex response known to
modulate SNA (van den Buuse et al., 2001). In contrast to
our anesthetized study, activation of the peripheral chemoreflex
pathway using hypoxia did not cause a change in SNA or
MAP in either the Lewis or LPK animals. This may be because
the exposure was not of sufficient time frame and/or in the
conscious state the animals were able to respond with a reflex
increase in ventilation. Additionally, and with specific reference
to the LPK animals, the peripheral chemoreceptors may be
already maximally activated. In human studies, in order to
test if tonic activation of excitatory chemoreceptor afferents
contributes to elevated SNA in patients with CKD, the effect of
chemoreflex deactivation on SNA is instead tested, comparing
the inhibitory effects of 100% oxygen with that of breathing
room air on MSNA and blood pressure (Hering et al., 2007). We
will require future experiments using alternative experimental
paradigms to investigate the effect of stimulation of the peripheral
chemoreflex on RSNA in the conscious state in our CKD
model. In the CKD animals however, the central chemoreflex
response demonstrated an attenuated sympathoexcitatory and
pressor response to hypercapnia when compared to the Lewis
control animals. This is directly comparable to our studies in
the anesthetized animals (Yao et al., 2015). The mechanisms
underlying these effects were not examined in this study, however
it is possible that tonic activation of the central chemoreflex
pathway in CKD may impair the ability of this reflex to drive
further increases in SNA.
Like chemoreflex activation, altered cardiovascular responses
to emotional stress have been implicated in the setting of high
blood pressure (Ming et al., 2004) and are often evident in
different models of hypertension (DiBona and Jones, 1995; Head
and Burke, 2004; D’Angelo et al., 2006). The principal response
to a stressful stimulus involves the activation of the SNS, release
of catecholamines from the adrenal medulla and activation of
the hypothalamic-pituitary-adrenocortical axis (Fontes et al.,
2011), mechanisms which may become altered during disease.
Comparable to our central chemoreflex response, we observed
diminution of the sympathetic responses to acute stress in the
LPK relative to Lewis, such that the acute rise in RSNA was
attenuated and no change in blood pressure was noted. In CKD,
previous studies have shown that sympathetic reactivity tomental
stress was either unchanged (Agarwal et al., 1991) or exaggerated
(Seliger et al., 2008). In these studies, however, sympathetic
reactivity was inferred indirectly from assessing differences in
the haemodynamic response to stress in test subjects. To our
knowledge, this is the first report to show sympathetic responses
to stress in CKD using direct recording of both SNA and blood
pressure. It is possible that the attenuated sympathetic response
and absence of a blood pressure response in the LPK may
have been the result of an effective activation of the buffering
capacity of the baroreflex; however we believe this is unlikely
because we have shown previously that baroreflex control of
RSNA and heart rate are markedly impaired in the LPK at this
age (Salman et al., 2014). Alternatively, it may indicate RSNA is
maximally increased in the LPK, such that it cannot be increased
further, or that in the LPK there is an underlying upregulation
of endogenous stress pathways (Armitage et al., 2012). Either
way, when this response and/or pathway are activated by external
factors, the net increase to maximal response is proportionally
less than in the control animals.
In conclusion, direct conscious recording of SNA in
undisturbed freely moving rats overcomes many of the
limitations that other indirect or direct assessments of
sympathetic activity are associated with. In a conscious rodent
model of CKD, we describe for the first time direct telemetric
recording of SNA to the kidney and provide evidence that high
blood pressure is significantly correlated with increased RSNA
and reduced renal function. The study further shows that the
renal disease is associated with both reduced central chemoreflex
and stress-induced regulation of RSNA and MAP, indicating
that the ability of the CNS to regulate sympathetic outflow and
blood pressure is compromised in CKD, therefore emphasizing
the complexity of this pathological condition. Findings from the
present study are relevant to better understanding the complex
nature of this global clinical problem and novel therapies such
as the targeting of sympathetic activity to specific organs to limit
cardiovascular disease in CKD.
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